SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 75,800
-900 (-1.17%)
Oct 2, 2026, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 5.94 trillion as of October 2, 2026. Its market cap has decreased by -26.55% in one year.
Market Cap
5.94T
Enterprise Value
5.60T
Revenue
861.34B
Ranking
n/a
PE Ratio
14.80
Stock Price
75,800.00
ChartMarket Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 5.94T, a decrease of -40.31%. That is a compound annual growth rate of -7.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 5.94T | -39.17% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 17.72T |
| Samsung Epis Holdings | 8.59T |
| HLB Co., Ltd. | 5.50T |
| Peptron | 3.07T |
| LigaChem Biosciences | 2.93T |
| SK bioscience | 2.82T |
| ABL Bio | 2.72T |
| Voronoi | 2.41T |